GGenetics Read More Opus Genetics partners with Global RDH12 AllianceAugust 1, 2025 (Image credit: ©ktsdesign/AdobeStock) To strengthen Opus Genetics’ gene therapy program focused on RDH12 gene mutations, the company announced…
UUnited States Read More Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United StatesJuly 19, 2025 (Image Credit: AdobeStock) Lupin Limited announced the launch of loteprednol etabonate ophthalmic suspension, 0.5%, in the United States.…